← back to search

Ruixin Zhu

Shanghai First Maternity and Infant Hospital · CN
Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Gut microbiota and health, Computational Drug Discovery Methods, Inflammatory Bowel Disease, and Liver Disease Diagnosis and Treatment.
h-index
37
citations
6,655
works
235
NIH funding
primary concept
email

Recent publications

Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis
Communications Biology 2024cited by 19position: middledoi
Identification and validation of microbial biomarkers from cross-cohort datasets using xMarkerFinder
Nature Protocols 2024cited by 19position: middledoi
Systematic identification of secondary bile acid production genes in global microbiome
mSystems 2024cited by 12position: middledoi
Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries
Nature Genetics 2023cited by 205position: middledoi
Microbial genes outperform species and SNVs as diagnostic markers for Crohn’s disease on multicohort fecal metagenomes empowered by artificial intelligence
Gut Microbes 2023cited by 36position: middledoi
Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer
Gut Microbes 2023cited by 30position: middledoi
Multi-kingdom microbiota analyses identifybacterial–fungal interactions and biomarkers of colorectal cancer acrosscohorts
Nature Microbiology 2022cited by 296position: middledoi
Targeting keystone species helps restore the dysbiosis of butyrate‐producing bacteria in nonalcoholic fatty liver disease
iMeta 2022cited by 45position: lastdoi
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease
Gut Microbes 2021cited by 439position: middledoi
Identification of microbial markers across populations in early detection of colorectal cancer
Nature Communications 2021cited by 237position: middledoi
Gastrointestinal sequelae 90 days after discharge for COVID-19
˜The œLancet. Gastroenterology & hepatology 2021cited by 135position: middledoi
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
˜The œLancet. Gastroenterology & hepatology 2020cited by 177position: middledoi
Difference in Pathomechanism Between Crohn’s Disease and Ulcerative Colitis Revealed by Colon Transcriptome
Inflammatory Bowel Diseases 2018cited by 45position: middledoi
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Gut 2017cited by 724position: middledoi
DevMouse, the mouse developmental methylome database and analysis tools
Database 2014cited by 14position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Lixin Zhu · Harvard University11 papers (2017–2024)Na Jiao · North China University of Water Resources and Electric Power11 papers (2017–2024)Dingfeng Wu · Children's Hospital of Zhejiang University7 papers (2020–2024)Ping Lan · Sun Yat-sen University6 papers (2018–2024)Wenxing Gao · Shihezi University5 papers (2023–2024)Liwen Tao · Shanghai First Maternity and Infant Hospital3 papers (2021–2024)Sheng Gao · Guangzhou University of Chinese Medicine3 papers (2023–2024)Sijing Cheng · Sun Yat-sen University3 papers (2020–2021)Zhanju Liu · Tongji University3 papers (2021–2023)Yichen Li · Tianjin University of Science and Technology3 papers (2020–2021)Yida Zhang · Macau University of Science and Technology2 papers (2021–2022)Zhipeng Tang · Anhui University of Traditional Chinese Medicine2 papers (2018–2020) · 2 papers (2023–2023)Guangjun Yan · Union Hospital2 papers (2020–2021)Chuan Tian · Oregon State University2 papers (2021–2022) · 2 papers (2024–2024)Lei Liu · Dalian Medical University2 papers (2022–2024)Yifeng Zou · Wuhan Polytechnic University2 papers (2020–2021)Susan S. Baker · Hospital for Sick Children2 papers (2017–2018)Yibo Huang · Nanjing Drum Tower Hospital2 papers (2020–2021)